Published on: 2025-05-21 14:13:37 Source: Solayer Staked SOL Author: Web3 & AI
The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepb... Stay informed with the latest.